Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02351934Phase 4Completed
Phase 4, randomised, open-label trial of furosemide in Colorectal disease, sponsored by Mayo Clinic. Primary endpoint: Length of Hospital Stay at 7 days. Started Feb 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02351934.